dpp4 vs glp 1 GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes Designing GLP-1 delivery: structural perspectives

Mechanisms of cancer cachexia

Access remains one of the biggest unresolved issues in obesity care

While that might not sound glamorous, its actually a stroke of biological geniusbecause the stomach is one of the most hostile environments in the body, constantly exposed to acids, bacteria, and inflammatory triggers

No matter the reason, the key is to transition with a plan

IMPROVED DIGESTION BPC-157 is a naturally-occurring peptide composed of amino acids that encourages protein synthesis and delivery throughout the body

health system is whether Medicaid and Medicare are prepared to treat obesity like the chronic disease it is